{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:41:40Z","timestamp":1791294100871,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Sanming Project of Medicine in Shenzhen","award":["SZSM201812002"],"award-info":[{"award-number":["SZSM201812002"]}]},{"name":"the Shenzhen Key Medical Discipline Construction Fund","award":["SZGSP012"],"award-info":[{"award-number":["SZGSP012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. However, some patients may have a prolonged or recurrent disease course, or present with life-threatening complications such as macrophage activation syndrome (MAS). In this study, we aimed to describe the incidence and clinical features of MAS in KFD and to access potential laboratory markers for the diagnosis of KFD-associated MAS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with KFD were retrospectively enrolled from January 2015 to November 2021 at Shenzhen Children\u2019s Hospital. Clinical data were collected from inpatient or outpatient medical records. Data collected included clinical manifestations, laboratory and imaging findings, treatment, and clinical outcomes. Data were analyzed using GraphPad Prism 8.0 statistical software (GraphPad Software Inc., La Jolla, CA, USA). A receiver operating characteristic (ROC) curve analysis was further performed to access the potential predictors for the KFD-MAS diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 58 patients with a histological diagnosis of KFD, 15 (25.9%) patients had MAS. Compared to patients without MAS, patients with KFD-MAS presented with a higher proportion of skin rash (26.7%, <jats:italic>p\u2009<\/jats:italic>=\u20090.01), glucocorticoid treatment (80%, <jats:italic>p\u2009<\/jats:italic>=\u20090.003), and disease recurrence (33.3%, <jats:italic>p\u2009<\/jats:italic>=\u20090.04). KFD-MAS patients had lower absolute peripheral white blood cell (WBC, <jats:italic>p\u2009<\/jats:italic>=\u20090.02), platelet (<jats:italic>p\u2009<\/jats:italic>=\u20090.002), serum albumin levels (<jats:italic>p\u2009<\/jats:italic>=\u20090.01), and lymphocyte count (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and higher lactate dehydrogenase (LDH) levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). ROC curve analysis showed that the cutoff values of absolute lymphocyte count, an absolute platelet count, serum albumin level, and serum LDH level for KFD-MAS diagnosis were\u2009&lt;\u20091235\/\u03bcL,\u2009&lt;\u2009171\u2009\u00d7\u200910<jats:sup>6<\/jats:sup>\/\u03bcL,\u2009&lt;\u200935.6\u00a0g\/L, and\u2009&gt;\u2009679\u00a0IU\/mL, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The presence of KFD-MAS in children may be more common than previously expected, especially in those with skin rash. KFD-MAS may be associated with a higher recurrence rate.  An extremely elevated serum LDH level and moderate to severe lymphopenia may be useful diagnostic markers for MAS in KFD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Not applicable; this was a retrospective study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00788-w","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:02:39Z","timestamp":1674640959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Macrophage activation syndrome in children with Kikuchi-Fujimoto disease"],"prefix":"10.1186","volume":"21","author":[{"given":"Zixuan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"788_CR1","unstructured":"Masab M, Surmachevska N, Farooq H. Kikuchi Disease. 2022."},{"key":"788_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jpeds.2020.08.063","volume":"229","author":"Y Yang","year":"2021","unstructured":"Yang Y, Lian H, Ma H, Zhao Y, Zhang Q, Zhang L, et al. Hemophagocytic Lymphohistiocytosis Associated with Histiocytic Necrotizing Lymphadenitis: A Clinical Study of 13 Children and Literature Review. J Pediatr. 2021;229:267-274.e3.","journal-title":"J Pediatr"},{"issue":"7","key":"788_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s00247-008-0894-x","volume":"38","author":"GY Lim","year":"2008","unstructured":"Lim GY, Cho B, Chung NG. Hemophagocytic lymphohistiocytosis preceded by Kikuchi disease in children. Pediatr Radiol. 2008;38(7):756\u201361.","journal-title":"Pediatr Radiol"},{"issue":"11","key":"788_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/PEC.0000000000000560","volume":"32","author":"JA Sykes","year":"2016","unstructured":"Sykes JA, Badizadegan K, Gordon P, Sokol D, Escoto M, Ten I, et al. Simultaneous Acquired Self-limited Hemophagocytic Lymphohistiocytosis and Kikuchi Necrotizing Lymphadenitis in a 16-Year-Old Teenage Girl: A Case Report and Review of the Literature. Pediatr Emerg Care. 2016;32(11):792\u20138.","journal-title":"Pediatr Emerg Care"},{"issue":"23","key":"788_CR5","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med. 2020;383(23):2255\u201373.","journal-title":"N Engl J Med"},{"issue":"7","key":"788_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020;72(7):1059\u201363.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"788_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40272-019-00367-1","volume":"22","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Cron RQ. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management. Paediatr Drugs. 2020;22(1):29\u201344.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"788_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood.2021013549","volume":"140","author":"A De Matteis","year":"2022","unstructured":"De Matteis A, Colucci M, Rossi MN, Caiello I, Merli P, Tumino N, et al. Expansion of CD4dimCD8+ T cells characterizes macrophage activation syndrome and other secondary HLH. Blood. 2022;140(3):262\u201373.","journal-title":"Blood"},{"issue":"7","key":"788_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219970","volume":"14","author":"SS Ahn","year":"2019","unstructured":"Ahn SS, Lee B, Kim D, Jung SM, Lee SW, Park MC, et al. Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR\/ACR\/PRINTO classification criteria. PLoS ONE. 2019;14(7): e0219970.","journal-title":"PLoS ONE"},{"issue":"1","key":"788_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00431-013-2131-3","volume":"173","author":"TY Kim","year":"2014","unstructured":"Kim TY, Ha KS, Kim Y, Lee J, Lee K, Lee J. Characteristics of Kikuchi-Fujimoto disease in children compared with adults. Eur J Pediatr. 2014;173(1):111\u20136.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"788_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/jpc.14628","volume":"56","author":"SN Selvanathan","year":"2020","unstructured":"Selvanathan SN, Suhumaran S, Sahu VK, Chong CY, Tan N, Thoon KC. Kikuchi-Fujimoto disease in children. J Paediatr Child Health. 2020;56(3):389\u201393.","journal-title":"J Paediatr Child Health"},{"issue":"1","key":"788_CR12","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1542\/peds.2004-0924","volume":"115","author":"HC Lin","year":"2005","unstructured":"Lin HC, Su CY, Huang SC. Kikuchi\u2019s disease in Asian children. Pediatrics. 2005;115(1):e92\u20136.","journal-title":"Pediatrics"},{"issue":"2","key":"788_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5858\/134.2.289","volume":"134","author":"CB Hutchinson","year":"2010","unstructured":"Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med. 2010;134(2):289\u201393.","journal-title":"Arch Pathol Lab Med"},{"key":"788_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpeds.2015.12.064","volume":"171","author":"HM Kang","year":"2016","unstructured":"Kang HM, Kim JY, Choi EH, Lee HJ, Yun KW, Lee H. Clinical Characteristics of Severe Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease) in Children. J Pediatr. 2016;171:208-12.e1.","journal-title":"J Pediatr"},{"key":"788_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.2147\/RMHP.S271283","volume":"13","author":"HJ Jung","year":"2020","unstructured":"Jung HJ, Lee IJ, Yoon SH. Risk Assessment of Recurrence and Autoimmune Disorders in Kikuchi Disease. Risk Manag Healthc Policy. 2020;13:1687\u201393.","journal-title":"Risk Manag Healthc Policy"},{"issue":"3","key":"788_CR16","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijid.2008.06.022","volume":"13","author":"JY Song","year":"2009","unstructured":"Song JY, Lee J, Park DW, Sohn JW, Suh SI, Kim IS, et al. Clinical outcome and predictive factors of recurrence among patients with Kikuchi\u2019s disease. Int J Infect Dis. 2009;13(3):322\u20136.","journal-title":"Int J Infect Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00788-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00788-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00788-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T10:03:27Z","timestamp":1674641007000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00788-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00788-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"15 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participating members were enrolled with the approval of the ethics committee of Shenzhen Children\u2019s Hospital and provided written consent from legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication of this anonymous information was obtained from patients\u2019 legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}